Holen Sie sich die Stockscreener-App
1.73
1.14%
-0.02
Schlusskurs vom Vortag:
$1.75
Offen:
$1.76
24-Stunden-Volumen:
130.89K
Relative Volume:
0.50
Marktkapitalisierung:
$135.58M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+3.59%
1M Leistung:
-14.78%
6M Leistung:
+93.51%
1J Leistung:
+42.98%
1-Tages-Spanne:
$1.69
$1.86
1-Wochen-Bereich:
$1.67
$1.93
52-Wochen-Spanne:
$0.5506
$6.19
Citius Oncology Inc Stock (CTOR) Company Profile
Firmenname
Citius Oncology Inc
Sektor
Telefon
(908) 967-6677
Adresse
11 COMMERCE DRIVE, CRANFORD
Vergleichen Sie CTOR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CTOR
Citius Oncology Inc
|
1.73 | 146.15M | 0 | 0 | 0 | 0.00 |
|
ZTS
Zoetis Inc
|
144.10 | 63.79B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.23 | 43.49B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.18 | 40.30B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.03 | 23.21B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
453.53 | 20.59B | 3.08B | 1.24B | 1.07B | 25.61 |
Citius Oncology Inc Stock (CTOR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-23 | Hochstufung | Maxim Group | Hold → Buy |
| 2024-11-27 | Eingeleitet | Maxim Group | Buy |
Citius Oncology Inc Aktie (CTOR) Neueste Nachrichten
Regression analysis insights on Citius Oncology Inc. performanceJuly 2025 Recap & Expert Curated Trade Ideas - newser.com
News impact scoring models applied to Citius Oncology Inc.2025 Short Interest & Reliable Price Action Trade Plans - newser.com
Why retail investors favor Citius Oncology Inc. stockGap Up & Weekly Setup with High ROI Potential - newser.com
How Citius Oncology Inc. stock benefits from strong dollarJuly 2025 Momentum & Entry and Exit Point Strategies - newser.com
Real time social sentiment graph for Citius Oncology Inc.2025 Market Trends & AI Forecasted Entry and Exit Points - newser.com
Building trade automation scripts for Citius Oncology Inc.2025 Price Momentum & Weekly Setup with ROI Potential - newser.com
Published on: 2025-10-29 00:05:52 - newser.com
Predicting Citius Oncology Inc. trend using moving averagesMarket Activity Summary & Fast Gain Swing Alerts - newser.com
Published on: 2025-10-28 05:08:21 - newser.com
What data driven models say about Citius Oncology Inc.’s futureWeekly Market Report & Safe Capital Preservation Plans - newser.com
Is Citius Oncology Inc. stock a buy on dipsM&A Rumor & Weekly High Momentum Picks - Fundação Cultural do Pará
What high frequency data says about Citius Oncology Inc.Trend Reversal & Entry and Exit Point Strategies - newser.com
Is Citius Oncology Inc. stock attractive for long term wealth buildingAnalyst Upgrade & Community Verified Watchlist Alerts - newser.com
Citius Oncology Stockholders Approve Share Increase - TipRanks
What analysts say about Citius Oncology Inc stockVWAP Trading Strategies & Investment Timing Techniques - earlytimes.in
Finanzdaten der Citius Oncology Inc-Aktie (CTOR)
Es liegen keine Finanzdaten für Citius Oncology Inc (CTOR) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
5.51%
0.30%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):